Learn more about retinal degenerations including the ways in which people with a retinal degeneration see their world. Find out what Retina International does and about its member societies together with contacts in your country.
Enjoy your visit
and please let us know if there is additional information you require by contacting email@example.com.
Please sign up for our Retina International Newsletter and we will keep you informed!
16h00 à 18h00
Troisième conférence scientifique internationale de Retina Pigmentosa ASBL- Gent, Belgique
Retina Pigmentosa ASBL s'associe au Professeur Bart Leroy et à l' "European Retinal Diesease Consortium" pour vous annoncer l'organisation de la troisième conférence scientifique international en Belgique. read
Patient Solidarity Day - 30 October 2013
IAPO Members in Africa create Patient Solidarity Day 2013
The 5th World Congress on CONTROVERSIES iN OPHTHALMOLOGY
Anterior Segment - Glaucoma - Retina read
World Ophthalmology Congress 2014 - Tokyo, Japan
Be sure to register for the world's largest international ophthalmology conference―the World Ophthalmology Congress®―to be held from April 2-6, 2014 in Tokyo, Japan. Simply click here to learn more and register to visit this global ophthalmology congress during the most beautiful time of year in Tokyo. What's more, if you sign up before October 18, 2013, you can take advantage of our special Early Bird fees! read
18th Retina International Worldconference in Paris, France
27th, 28th and 29th June 2014 in Paris (France) presents ophthalmologists, scientists and patients with a unique opportunity to learn about the latest developments in basic science and clinical trials for inherited retinal degenerative diseases (RP, Usher syndrome, Stargardt etc.) and AMD. read
The 1st Asia-Australia Congress on CONTROVERSIES IN OPHTHALMOLOGY
Anterior Segment - Glaucoma - Retina read
iMove an iPhone app that supports visually impaired persons to move in urban environments
Retina Italia Onlus commissioned EveryWare Technologies to develop iMove, an iPhone app that supports visually impaired persons to autonomously move in urban environments. Thanks to iMove, an iPhone is now capable of reading the current address and the nearby shops. Moreover, it is possible to create audio notes, that are played every time a user gets close to a given place. iMove is a free app that is distributed world-wide through the App Store (https://itunes.apple.com/app/imove/id593874954). read
Recommendations for Genetic Testing of Inherited Eye Diseases
Report of the American Academy of Ophthalmology Task Force on Genetic Testing read
DRUGSFORD" consortium "Preclinical development of drugs and drug delivery technology for the treatment of inherited photoreceptor degeneration" successfully started!
The DRUGSFORD" consortium started successfully its work on the "Preclinical development of drugs and drug delivery technology for the treatment of inherited photoreceptor degeneration", co-ordinated by Dr. Francois Paquet-Durand. The total value of the consortium award is EURO4,971,428. read
FDA Panel Votes In Favor Of Retinal Prosthesis System Argus2
FDA advisory panel recommends that the federal watchdog agency approve a humanitarian device exemption for Second Sight's Argus II "bionic eye" retinal implant. read
New research suggests proinsulin administration may reduce vision loss in retinitis pigmentosa models
Novel research from the University of Alicante, Spain has suggested that the administration of proinsulin may be capable of slowing retinal degeneration and vision loss in a model of retinitis pigmentosa. read
Regeneron announces FDA approval for anti-VEGF Eylea to treat macular edema following CRVO
Regenerom Pharmaceuticals Inc (REGN, Tarrytown, New York) have announced the receipt of FDA approval for their VEGF trap eye product for the treatment of macular edema following central retinal vein occlusion. read
We can make a difference!
Michael Griffith founded in 1984 Fighting Blindness Ireland in the view to find a cure for Retinitis pigmentosa. Please see how the partnership between patients and scientists lead the way from genetic research to gene therapy. read